Michigan Institute for Clinical and Health Research (MCHR)

密歇根临床与健康研究所 (MCHR)

基本信息

项目摘要

The CTSA funding to the Michigan Institute for Clinical and Health Research (MICHR) in 2007 marked the beginning of a transformation of clinical-translational research (CTR) at the University of Michigan (UM). This award, coupled with strong institutional support and growing faculty engagement, enabled UM to evolve from a predominantly basic science research institution to one with a comprehensive research portfolio. This has been achieved on the foundation of: integrated and innovative training and educational programs that have touched nearly 2,000 trainees, faculty and staff; centralization and optimization of previously fragmented research services to create innovative opportunities for users; $10.2M distributed for pilot studies to accelerate innovation; and researcher participation in new partnerships with our communities and across the CTSA National Consortium. In the renewal period, CTSA funding leveraged with robust institutional support will enable MICHR to pursue 5 Overarching Objectives: 1) Optimize training and mentoring to create the next generation of research teams and clinical and translational investigators; 2) Augment infrastructure and refine research services to reduce barriers and maximize research productivity across the entire translational research continuum; 3) Foster collaborations and leverage innovative approaches and technologies to catalyze discovery; 4) Enhance community- and practice-based partnerships to assure bi-directional learning, research, and implementation of findings to benefit health; 5) Actively lead and contribute to national CTSA Consortium activities and engage in cross-CTSA collaborations. These will be achieved by: expanding education into new areas to strengthen the pipeline of CTR investigators and deploying more flexible training tools; strer^gthening existing services and launching new ones to impact study start-up times and recruitment; employing major informatics investments to fully integrate the needs of CTR investigators into IT landscape; utilizing new practice-based research networl<s; expanding evaluation to efficiently assess and optimize our performance. MICHR will be the engine of improvement and innovation in the conduct of high-quality, high impact-clinical and translational research to advance the health of Michigan and the nation.
2007年CTSA对密歇根临床与健康研究所(MICHR)的资助标志着 密歇根大学(UM)临床-转化研究(CTR)转型的开始。这 奖项,加上强有力的机构支持和日益增长的教职员工参与度,使密歇根大学能够从 从一个以基础科学研究为主的机构转变为一个拥有全面研究组合的机构。这有 在以下基础上实现:综合和创新的培训和教育方案 接触了近2,000名学员、教职员工;集中化和优化了以前分散的 研究服务,为用户创造创新机会;分发1020万美元用于试点研究,以 加快创新;以及研究人员参与与我们社区和整个世界的新伙伴关系 CTSA国家联盟。在更新期间,CTSA资金在强有力的机构支持下发挥杠杆作用 将使MICHR能够实现5个总体目标:1)优化培训和指导,以创建下一个 产生研究团队以及临床和翻译研究人员;2)加强基础设施和 优化研究服务,以减少障碍并最大限度地提高整个翻译行业的研究效率 研究连续体;3)促进协作并利用创新方法和技术 促进发现;4)加强基于社区和实践的伙伴关系,以确保双向 学习、研究和实施有益于健康的研究成果;5)积极领导和促进 国家CTSA联盟活动,并参与跨CTSA合作。这些目标将通过以下方式实现: 将教育扩展到新的领域,以加强CTR调查人员的渠道,并部署更多 灵活的培训工具;加强现有服务并推出新服务,以影响研究启动时间 和招聘;利用重大信息学投资,充分整合CTR调查人员的需求 走进IT领域;利用新的实践性研究网络;S;拓展评估以高效评估 并优化我们的表现。MICHR将成为改进和创新行为的引擎 高质量、高影响力的临床和转化性研究,以促进密歇根州和全国的健康。

项目成果

期刊论文数量(9)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Agreement of Ocular Symptom Reporting Between Patient-Reported Outcomes and Medical Records.
  • DOI:
    10.1001/jamaophthalmol.2016.5551
  • 发表时间:
    2017-03-01
  • 期刊:
  • 影响因子:
    8.1
  • 作者:
    Valikodath NG;Newman-Casey PA;Lee PP;Musch DC;Niziol LM;Woodward MA
  • 通讯作者:
    Woodward MA
Sustained Obesity and Depressive Symptoms over 6 Years: Race by Gender Differences in the Health and Retirement Study.
  • DOI:
    10.3389/fnagi.2016.00312
  • 发表时间:
    2016
  • 期刊:
  • 影响因子:
    4.8
  • 作者:
    Carter JD;Assari S
  • 通讯作者:
    Assari S
The effects of cystoscopy and hydrodistention on symptoms and bladder capacity in interstitial cystitis/bladder pain syndrome.
膀胱镜检查和水扩张对间质性膀胱炎/膀胱疼痛综合征症状和膀胱容量的影响。
  • DOI:
    10.1002/nau.23555
  • 发表时间:
    2018
  • 期刊:
  • 影响因子:
    2
  • 作者:
    Kirk,PeterS;Santiago-Lastra,Yahir;Qin,Yongmei;Stoffel,JohnT;Clemens,JamesQ;Cameron,AnneP
  • 通讯作者:
    Cameron,AnneP
{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

George Alexander Mashour其他文献

George Alexander Mashour的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('George Alexander Mashour', 18)}}的其他基金

Role of preoptic hypothalamus in sleep-dependent cognition after surgery and general anesthesia
视前下丘脑在手术和全身麻醉后睡眠依赖性认知中的作用
  • 批准号:
    10494980
  • 财政年份:
    2022
  • 资助金额:
    $ 47.82万
  • 项目类别:
Role of preoptic hypothalamus in sleep-dependent cognition after surgery and general anesthesia
视前下丘脑在手术和全身麻醉后睡眠依赖性认知中的作用
  • 批准号:
    10686190
  • 财政年份:
    2022
  • 资助金额:
    $ 47.82万
  • 项目类别:
TEAMSS – Transforming Expanded Access to Maximize Support & Study
TEAMSS – 改变扩展访问范围以最大限度地提供支持
  • 批准号:
    10414026
  • 财政年份:
    2018
  • 资助金额:
    $ 47.82万
  • 项目类别:
TEAMSS – Transforming Expanded Access to Maximize Support & Study
TEAMSS – 改变扩展访问范围以最大限度地提供支持
  • 批准号:
    10164885
  • 财政年份:
    2018
  • 资助金额:
    $ 47.82万
  • 项目类别:
Michigan Institute for Clinical and Health Research (MICHR)
密歇根临床与健康研究所 (MICHR)
  • 批准号:
    10199208
  • 财政年份:
    2017
  • 资助金额:
    $ 47.82万
  • 项目类别:
Role of the Prefrontal Cortex in the Control of Arousal States
前额叶皮层在控制唤醒状态中的作用
  • 批准号:
    10380066
  • 财政年份:
    2015
  • 资助金额:
    $ 47.82万
  • 项目类别:
Role of the Prefrontal Cortex in the Control of Arousal States
前额叶皮层在控制唤醒状态中的作用
  • 批准号:
    9765454
  • 财政年份:
    2015
  • 资助金额:
    $ 47.82万
  • 项目类别:
Frontoparietal Mechanisms of Anesthetic-induced Unconsciousness
麻醉引起无意识的额顶叶机制
  • 批准号:
    8518394
  • 财政年份:
    2012
  • 资助金额:
    $ 47.82万
  • 项目类别:
Frontoparietal Mechanisms of Anesthetic-induced Unconsciousness
麻醉引起无意识的额顶叶机制
  • 批准号:
    8634122
  • 财政年份:
    2012
  • 资助金额:
    $ 47.82万
  • 项目类别:
Frontoparietal Mechanisms of Anesthetic-induced Unconsciousness
麻醉引起无意识的额顶叶机制
  • 批准号:
    8369549
  • 财政年份:
    2012
  • 资助金额:
    $ 47.82万
  • 项目类别:

相似海外基金

Rational design of rapidly translatable, highly antigenic and novel recombinant immunogens to address deficiencies of current snakebite treatments
合理设计可快速翻译、高抗原性和新型重组免疫原,以解决当前蛇咬伤治疗的缺陷
  • 批准号:
    MR/S03398X/2
  • 财政年份:
    2024
  • 资助金额:
    $ 47.82万
  • 项目类别:
    Fellowship
CAREER: FEAST (Food Ecosystems And circularity for Sustainable Transformation) framework to address Hidden Hunger
职业:FEAST(食品生态系统和可持续转型循环)框架解决隐性饥饿
  • 批准号:
    2338423
  • 财政年份:
    2024
  • 资助金额:
    $ 47.82万
  • 项目类别:
    Continuing Grant
Re-thinking drug nanocrystals as highly loaded vectors to address key unmet therapeutic challenges
重新思考药物纳米晶体作为高负载载体以解决关键的未满足的治疗挑战
  • 批准号:
    EP/Y001486/1
  • 财政年份:
    2024
  • 资助金额:
    $ 47.82万
  • 项目类别:
    Research Grant
Metrology to address ion suppression in multimodal mass spectrometry imaging with application in oncology
计量学解决多模态质谱成像中的离子抑制问题及其在肿瘤学中的应用
  • 批准号:
    MR/X03657X/1
  • 财政年份:
    2024
  • 资助金额:
    $ 47.82万
  • 项目类别:
    Fellowship
CRII: SHF: A Novel Address Translation Architecture for Virtualized Clouds
CRII:SHF:一种用于虚拟化云的新型地址转换架构
  • 批准号:
    2348066
  • 财政年份:
    2024
  • 资助金额:
    $ 47.82万
  • 项目类别:
    Standard Grant
The Abundance Project: Enhancing Cultural & Green Inclusion in Social Prescribing in Southwest London to Address Ethnic Inequalities in Mental Health
丰富项目:增强文化
  • 批准号:
    AH/Z505481/1
  • 财政年份:
    2024
  • 资助金额:
    $ 47.82万
  • 项目类别:
    Research Grant
ERAMET - Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
ERAMET - 快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
  • 批准号:
    10107647
  • 财政年份:
    2024
  • 资助金额:
    $ 47.82万
  • 项目类别:
    EU-Funded
BIORETS: Convergence Research Experiences for Teachers in Synthetic and Systems Biology to Address Challenges in Food, Health, Energy, and Environment
BIORETS:合成和系统生物学教师的融合研究经验,以应对食品、健康、能源和环境方面的挑战
  • 批准号:
    2341402
  • 财政年份:
    2024
  • 资助金额:
    $ 47.82万
  • 项目类别:
    Standard Grant
Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
  • 批准号:
    10106221
  • 财政年份:
    2024
  • 资助金额:
    $ 47.82万
  • 项目类别:
    EU-Funded
Recite: Building Research by Communities to Address Inequities through Expression
背诵:社区开展研究,通过表达解决不平等问题
  • 批准号:
    AH/Z505341/1
  • 财政年份:
    2024
  • 资助金额:
    $ 47.82万
  • 项目类别:
    Research Grant
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了